Response of fibroblasts to transforming growth factor-β1 on two-dimensional and in three-dimensional hyaluronan hydrogels

Tissue Engineering - Part A

Volumn 18, Issue 23-24, 2012, Pages 2528-2538

  Chen, Xia ^a   Thibeault, Susan L ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3D CULTURE; COLLAGEN I; CYTOKINES; EXTRACELLULAR MATRICES; FIBRONECTIN EXPRESSION; HYALURONAN; HYALURONAN HYDROGELS; IMMUNOCYTOCHEMISTRY; IN-VIVO; MATRIX METALLOPROTEINASE-1; MORPHOLOGICAL FEATURES; MRNA EXPRESSION; MULTIPLE FUNCTION; MYOFIBROBLASTS; MYOFILAMENTS; PROTEIN EXPRESSIONS; QUANTITATIVE POLYMERASE CHAIN REACTION; RECEPTOR EXPRESSION; SMOOTH MUSCLE ACTINS; TISSUE CULTURE POLYSTYRENES; TRANSFORMING GROWTH FACTORS; WESTERN BLOTS; WOUND HEALING;

CYTOLOGY; ENZYME INHIBITION; FIBROBLASTS; GENE EXPRESSION; HYDROGELS; POLYMERASE CHAIN REACTION; POLYSTYRENES; PROTEINS; THREE DIMENSIONAL COMPUTER GRAPHICS; TISSUE CULTURE; TWO DIMENSIONAL;

THREE DIMENSIONAL;

ACTA2 PROTEIN, HUMAN; ACTIN; CARBYLAN GSX; CARBYLAN-GSX; DRUG DERIVATIVE; GELATIN; HYALURONIC ACID; MATRIX METALLOPROTEINASE; MESSENGER RNA; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; BIOSYNTHESIS; CELL DIVISION; CHEMISTRY; COMPARATIVE STUDY; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECT; EXTRACELLULAR MATRIX; FIBROBLAST; GENE EXPRESSION REGULATION; GENETICS; HUMAN; HYDROGEL; METABOLISM; METHODOLOGY; MUSCLE DEVELOPMENT; MYOFIBROBLAST; VOCAL CORD;

ACTINS; CELL CULTURE TECHNIQUES; CELL DIVISION; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FIBROBLASTS; GELATIN; GENE EXPRESSION REGULATION; HUMANS; HYALURONIC ACID; HYDROGELS; MATRIX METALLOPROTEINASES; MUSCLE DEVELOPMENT; MYOFIBROBLASTS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA1; VOCAL CORDS; YOUNG ADULT;

EID: 84869814784     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2012.0094     Document Type: Article

References (68)

1. Clark, R.A. Biology of dermal wound repair. Dermatol Clin 11, 647, 1993.
2. Bissell, M.J., Hall, H.G., and Parry, G. How does the extracellular matrix direct gene expression? J Theor Biol 99, 31, 1982.
3. Schachtrup, C., Ryu, J.K., Helmrick, M.J., Vagena, E., Galanakis, D.K., Degen, J.L., et al. Fibrinogen triggers astrocyte scar formation by promoting the availability of active TGF-beta after vascular damage. J Neurosci 30, 5843, 2010.
4. Tandon, A., Tovey, J.C., Sharma, A., Gupta, R., and Mohan, R.R. Role of transforming growth factor Beta in corneal function, biology and pathology. Curr Mol Med 10, 565, 2010.
5. Grande, J.P. Role of transforming growth factor-beta in tissue injury and repair. Proc Soc Exp Biol Med 214, 27, 1997.
6. Massaous, J., and Hata, A. TGF-beta signalling through the Smad pathway. Trends Cell Biol 7, 187, 1997.
7. Sporn, M.B., and Roberts, A.B. Transforming growth factorbeta: recent progress and new challenges. J Cell Biol 119, 1017, 1992.
8. Rifkin, D.B., Kojima, S., Abe, M., and Harpel, J.G. TGF-beta: structure, function, and formation. Thromb Haemost 70, 177, 1993.
9. Branton, M.H., and Kopp, J.B. TGF-beta and fibrosis. Microbes Infect 1, 1349, 1999.
10. Border, W.A., and Noble, N.A. Transforming growth factor beta in tissue fibrosis. N Engl J Med 331, 1286, 1994.
11. Krummel, T.M., Michna, B.A., Thomas, B.L., Sporn, M.B., Nelson, J.M., Salzberg, A.M., et al. Transforming growth factor beta (TGF-beta) induces fibrosis in a fetal wound model. J Pediatr Surg 23, 647, 1988.
12. Vyas, B., Ishikawa, K., Duflo, S., Chen, X., and Thibeault, S.L. Inhibitory effects of hepatocyte growth factor and interleukin- 6 on transforming growth factor-beta1 mediated vocal fold fibroblast-myofibroblast differentiation. Ann Otol Rhinol Laryngol 119, 350, 2010.
13. Kraehenbuehl, T.P., Zammaretti, P., Van der Vlies, A.J., Schoenmakers, R.G., Lutolf, M.P., Jaconi, M.E., et al. Threedimensional extracellular matrix-directed cardioprogenitor differentiation: systematic modulation of a synthetic cellresponsive PEG-hydrogel. Biomaterials 29, 2757, 2008.
14. Chen, X., and Thibeault, S.L. Biocompatibility of a synthetic extracellular matrix on immortalized vocal fold fibroblasts in 3-D culture. Acta Biomater 6, 2940, 2010.
15. Duflo, S., Thibeault, S.L., Li, W., Shu, X.Z., and Prestwich, G. Effect of a synthetic extracellular matrix on vocal fold lamina propria gene expression in early wound healing. Tissue Eng 12, 3201, 2006.
16. Duflo, S., Thibeault, S.L., Li, W., Shu, X.Z., and Prestwich, G.D. Vocal fold tissue repair in vivo using a synthetic extracellular matrix. Tissue Eng 12, 2171, 2006.
17. Thibeault, S.L., Klemuk, S.A., Chen, X., and Quinchia Johnson, B.H. In vivo engineering of the vocal fold ECM with injectable HA hydrogels-late effects on tissue repair and biomechanics in a rabbit model. J Voice 25, 229, 2011.
18. Serban, M.A., Liu, Y., and Prestwich, G.D. Effects of extracellular matrix analogues on primary human fibroblast behavior. Acta Biomater 4, 67, 2008.
19. Meran, S., Thomas, D., Stephens, P., Martin, J., Bowen, T., Phillips, A., et al. Involvement of hyaluronan in regulation of fibroblast phenotype. J Biol Chem 282, 25687, 2007.
20. Meran, S., Luo, D.D., Simpson, R., Martin, J., Wells, A., Steadman, R., et al. Hyaluronan facilitates transforming growth factor-beta1-dependent proliferation via CD44 and epidermal growth factor receptor interaction. J Biol Chem 286, 17618, 2011.
21. Shu, X.Z., Liu, Y., Luo, Y., Roberts, M.C., and Prestwich, G.D. Disulfide cross-linked hyaluronan hydrogels. Biomacromolecules 3, 1304, 2002.
22. Shu, X.Z., Liu, Y., Palumbo, F., and Prestwich, G.D. Disulfide- crosslinked hyaluronan-gelatin hydrogel films: a covalent mimic of the extracellular matrix for in vitro cell growth. Biomaterials 24, 3825, 2003.
23. Shu, X.Z., Ghosh, K., Liu, Y., Palumbo, F.S., Luo, Y., Clark, R.A., et al. Attachment and spreading of fibroblasts on an RGD peptide-modified injectable hyaluronan hydrogel. J Biomed Mater Res A 68, 365, 2004.
24. Zheng Shu, X., Liu, Y., Palumbo, F.S., Luo, Y., and Prestwich, G.D. In situ crosslinkable hyaluronan hydrogels for tissue engineering. Biomaterials 25, 1339, 2004.
25. Chen, X., and Thibeault, S.L. Characteristics of age-related changes in cultured human vocal fold fibroblasts. Laryngoscope 118, 1700, 2008.
26. Thibeault, S.L., Li, W., and Bartley, S. A method for identification of vocal fold lamina propria fibroblasts in culture. Otolaryngol Head Neck Surg 139, 816, 2008.
27. Chen, X., and Thibeault, S.L. Novel isolation and biochemical characterization of immortalized fibroblasts for tissue engineering vocal fold lamina propria. Tissue Eng Part C Methods 15, 201, 2009.
28. Zetterberg, A., and Engstrom, W. Mitogenic effect of alkaline pH on quiescent, serum-starved cells. Proc Natl Acad Sci U S A 78, 4334, 1981.
29. Kim, M.S., Yeon, J.H., and Park, J.K. A microfluidic platform for 3-dimensional cell culture and cell-based assays. Biomed Microdevices 9, 25, 2007.
30. Semino, C.E., Merok, J.R., Crane, G.G., Panagiotakos, G., and Zhang, S. Functional differentiation of hepatocyte-like spheroid structures from putative liver progenitor cells in three-dimensional peptide scaffolds. Differentiation 71, 262, 2003.
31. David, L. and Smith, W.A.R. CellTiter-Glo Luminescent Cell Viability Assay: Application for Viability Studies of Cells Grown in Agarose. Cell Note Promega 17, 16, 2007.
32. Crouch, S.P., Kozlowski, R., Slater, K.J., and Fletcher, J. The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity. J Immunol Methods 160, 81, 1993.
33. Kangas, L., Gronroos, M., and Nieminen, A.L. Bioluminescence of cellular ATP: a new method for evaluating cytotoxic agents in vitro. Med Biol 62, 338, 1984.
34. Larionov, A., Krause, A., and Miller, W. A standard curve based method for relative real time PCR data processing. BMC Bioinformatics 6, 62, 2005.
35. Gillette, B.M., Jensen, J.A., Tang, B., Yang, G.J., Bazargan- Lari, A., Zhong, M., et al. In situ collagen assembly for integrating microfabricated three-dimensional cell-seeded matrices. Nat Mater 7, 636, 2008.
36. Schor, S.L. Cell proliferation and migration on collagen substrata in vitro. J Cell Sci 41, 159, 1980.
37. Yun, E.J., Yon, B., Joo, M.K., and Jeong, B. Cell therapy for skin wound using fibroblast encapsulated poly(ethylene glycol)-poly(l-alanine) thermogel. Biomacromolecules 13, 1106, 2012.
38. Kumar, G., Tison, C.K., Chatterjee, K., Pine, P.S., McDaniel, J.H., Salit, M.L., et al. The determination of stem cell fate by 3D scaffold structures through the control of cell shape. Biomaterials 32, 9188, 2011.
39. Glowacki, J., Trepman, E., and Folkman, J. Cell shape and phenotypic expression in chondrocytes. Proc Soc Exp Biol Med 172, 93, 1983.
40. Klein, F., Richter, B., Striebel, T., Franz, C.M., von Freymann, G., Wegener, M., et al. Two-component polymer scaffolds for controlled three-dimensional cell culture. Adv Mater 23, 1341, 2011.
41. Gruber, H.E., and Hanley, E.N., Jr. Human disc cells in monolayer vs 3D culture: cell shape, division and matrix formation. BMC Musculoskelet Disord 1, 1, 2000.
42. Shah, J.V. Cells in tight spaces: the role of cell shape in cell function. J Cell Biol 191, 233, 2010.
43. Folkman, J., and Moscona, A. Role of cell shape in growth control. Nature 273, 345, 1978.
44. Chen, C.S., Mrksich, M., Huang, S., Whitesides, G.M., and Ingber, D.E. Geometric control of cell life and death. Science 276, 1425, 1997.
45. Bott, K., Upton, Z., Schrobback, K., Ehrbar, M., Hubbell, J.A., Lutolf, M.P., et al. The effect of matrix characteristics on fibroblast proliferation in 3D gels. Biomaterials 31, 8454, 2010.
46. Chen, G., and Khalil, N. TGF-beta1 increases proliferation of airway smooth muscle cells by phosphorylation of map kinases. Respir Res 7, 2, 2006.
47. Strutz, F., Zeisberg, M., Renziehausen, A., Raschke, B., Becker, V., van Kooten, C., et al. TGF-beta 1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2). Kidney Int 59, 579, 2001.
48. Moses, H.L., Yang, E.Y., and Pietenpol, J.A. TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 63, 245, 1990.
49. Goodman, L.V., and Majack, R.A. Vascular smooth muscle cells express distinct transforming growth factor-beta receptor phenotypes as a function of cell density in culture. J Biol Chem 264, 5241, 1989.
50. Majack, R.A. Beta-type transforming growth factor specifies organizational behavior in vascular smooth muscle cell cultures. J Cell Biol 105, 465, 1987.
51. Serini, G., and Gabbiani, G. Mechanisms of myofibroblast activity and phenotypic modulation. Exp Cell Res 250, 273, 1999.
52. Darby, I.A., and Hewitson, T.D. Fibroblast differentiation in wound healing and fibrosis. Int Rev Cytol 257, 143, 2007.
53. Phan, S.H. The myofibroblast in pulmonary fibrosis. Chest 122, 286S, 2002.
54. Grinnell, F. Fibroblasts, myofibroblasts, and wound contraction. J Cell Biol 124, 401, 1994.
55. Eikmans, M., Baelde, J.J., de Heer, E., and Bruijn, J.A. ECM homeostasis in renal diseases: a genomic approach. J Pathol 200, 526, 2003.
56. Iwano, M., and Neilson, E.G. Mechanisms of tubulointerstitial fibrosis. Curr Opin Nephrol Hypertens 13, 279, 2004.
57. Ronty, M.J., Leivonen, S.K., Hinz, B., Rachlin, A., Otey, C.A., Kahari, V.M., et al. Isoform-specific regulation of the actinorganizing protein palladin during TGF-beta1-induced myofibroblast differentiation. J Invest Dermatol 126, 2387, 2006.
58. Garrett, Q., Khaw, P.T., Blalock, T.D., Schultz, G.S., Grotendorst, G.R., and Daniels, J.T. Involvement of CTGF in TGF-beta1-stimulation of myofibroblast differentiation and collagen matrix contraction in the presence of mechanical stress. Invest Ophthalmol Vis Sci 45, 1109, 2004.
59. Rosenbaum, J., Blazejewski, S., Preaux, A.M., Mallat, A., Dhumeaux, D., and Mavier, P. Fibroblast growth factor 2 and transforming growth factor beta 1 interactions in human liver myofibroblasts. Gastroenterology 109, 1986, 1995.
60. Wells, R.G., and Discher, D.E. Matrix elasticity, cytoskeletal tension, and TGF-beta: the insoluble and soluble meet. Sci Signal 1, pe13, 2008.
61. Wynn, T.A. Cellular and molecular mechanisms of fibrosis. J Pathol 214, 199, 2008.
62. Rousseau, B., Hirano, S., Chan, R.W., Welham, N.V., Thibeault, S.L., Ford, C.N., et al. Characterization of chronic vocal fold scarring in a rabbit model. J Voice 18, 116, 2004.
63. Tateya, T., Tateya, I., Sohn, J.H., and Bless, D.M. Histologic characterization of rat vocal fold scarring. Ann Otol Rhinol Laryngol 114, 183, 2005.
64. Hirano, S., Bless, D.M., Rousseau, B., Welham, N., Scheidt, T., and Ford, C.N. Fibronectin and adhesion molecules on canine scarred vocal folds. Laryngoscope 113, 966, 2003.
65. Gomez, D.E., Alonso, D.F., Yoshiji, H., and Thorgeirsson, U.P. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 74, 111, 1997.
66. Attisano, L., Wrana, J.L., Lopez-Casillas, F., and Massague, J. TGF-beta receptors and actions. Biochim Biophys Acta 1222, 71, 1994.
67. Wrana, J.L., Attisano, L., Wieser, R., Ventura, F., and Massague, J. Mechanism of activation of the TGF-beta receptor. Nature 370, 341, 1994.
68. Nakao, A., Imamura, T., Souchelnytskyi, S., Kawabata, M., Ishisaki, A., Oeda, E., et al. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J 16, 5353, 1997.